CSL to slash headcount by 15% and spinout its CSL Seqirus vaccines business
By Dominic Tyer (European Pharmaceutical Review)
Sanofi’s Tzield type 1 diabetes immunotherapy wins UK first
By Catherine Eckford (European Pharmaceutical Review)
Daewoong’s microneedle patch marks semaglutide first in obesity
By Catherine Eckford (European Pharmaceutical Review)
Trump executive order targets US pharma supply chain resilience
By Dominic Tyer (European Pharmaceutical Review)
Amid FDA turmoil Sarepta’s gene therapy worries begin to ease
By Dominic Tyer (European Pharmaceutical Review)